A Kisspeptin Protocol refers to a specific clinical or research regimen involving the administration of kisspeptin peptides, the primary physiological drivers of GnRH release in the hypothalamus. In clinical practice, this protocol is often employed to stimulate or assess the integrity of the Hypothalamic-Pituitary-Gonadal (HPG) axis function. It represents a targeted approach to evaluating reproductive endocrinology potential. This precise stimulation helps differentiate central hypogonadism from peripheral causes.
Origin
The term originates from the discovery of the KISS1 gene, which encodes the kisspeptin family of proteins, and the subsequent development of defined administration schedules, hence the “Protocol.” Kisspeptin’s role as the master regulator of puberty and reproductive cycling established its clinical significance. Its name itself is a historical nod to its discovery site, though its function is purely physiological.
Mechanism
The protocol functions by delivering exogenous kisspeptin, which binds to its cognate receptor (KISS1R) on GnRH-producing neurons in the hypothalamus. This binding powerfully stimulates pulsatile release of Gonadotropin-Releasing Hormone (GnRH). Subsequently, GnRH travels to the pituitary gland, prompting the release of LH and FSH, thereby initiating the downstream cascade of gonadal steroid production. The response kinetics observed during the protocol provide vital diagnostic information.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.